1. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival 
Simon Maltais, MD, PhD, Hartzell V. Schaff, MD, Richard C. Daly, MD, Rakesh M. Suri, MD, PhD, Joseph A. Dearani, MD, Thoralf M. Sundt, MD, Maurice Enriquez-Sarano, MD, Yan Topilsky, MD, Soon J. Park, MD, MSc 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 142, Issue 5, Pages (November 2011)
DOI: /j.jtcvs
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Overall reported 1-, 5-, and 10-year survivals for the entire cohort were 82.7%, 55.2%, and 24.3%, respectively.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Survival results for propensity-matched patients. There were no differences between patients undergoing MVR or MVP. Survival was comparable between propensity-matched groups of patients (P = .72). MV, Mitral valve.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions